These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31084378)

  • 21. Pragmatic (trial) informatics: a perspective from the NIH Health Care Systems Research Collaboratory.
    Richesson RL; Green BB; Laws R; Puro J; Kahn MG; Bauck A; Smerek M; Van Eaton EG; Zozus M; Hammond WE; Stephens KA; Simon GE
    J Am Med Inform Assoc; 2017 Sep; 24(5):996-1001. PubMed ID: 28340241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.
    Anstrom KJ; Noth I; Flaherty KR; Edwards RH; Albright J; Baucom A; Brooks M; Clark AB; Clausen ES; Durheim MT; Kim DY; Kirchner J; Oldham JM; Snyder LD; Wilson AM; Wisniewski SR; Yow E; Martinez FJ;
    Respir Res; 2020 Mar; 21(1):68. PubMed ID: 32164673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials.
    van Staa TP; Dyson L; McCann G; Padmanabhan S; Belatri R; Goldacre B; Cassell J; Pirmohamed M; Torgerson D; Ronaldson S; Adamson J; Taweel A; Delaney B; Mahmood S; Baracaia S; Round T; Fox R; Hunter T; Gulliford M; Smeeth L
    Health Technol Assess; 2014 Jul; 18(43):1-146. PubMed ID: 25011568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed.
    Bell KJL; McCullough A; Del Mar C; Glasziou P
    BMC Med Res Methodol; 2017 Dec; 17(1):174. PubMed ID: 29272994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applying the pragmatic-explanatory continuum indicator summary to the implementation of a physical activity coaching trial in chronic obstructive pulmonary disease.
    Nguyen HQ; Moy ML; Fan VS; Gould MK; Xiang A; Bailey A; Desai S; Coleman KJ
    Nurs Outlook; 2018 Sep; 66(5):455-463. PubMed ID: 30144938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Affecting Post-trial Sustainment or De-implementation of Study Interventions: A Narrative Review.
    Green T; Bosworth HB; Coronado GD; DeBar L; Green BB; Huang SS; Jarvik JG; Mor V; Zatzick D; Weinfurt KP; Check DK
    J Gen Intern Med; 2024 May; 39(6):1029-1036. PubMed ID: 38216853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement.
    Taljaard M; Li F; Qin B; Cui C; Zhang L; Nicholls SG; Carroll K; Mitchell SL
    Clin Trials; 2022 Feb; 19(1):86-96. PubMed ID: 34841910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
    Dal-Ré R; Janiaud P; Ioannidis JPA
    BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pragmatic patient engagement in designing pragmatic oncology clinical trials.
    Davies-Teye BB; Medeiros M; Chauhan C; Baquet CR; Mullins CD
    Future Oncol; 2021 Oct; 17(28):3691-3704. PubMed ID: 34337970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Considerations When Designing and Implementing Pragmatic Clinical Trials That Include Older Hispanics.
    Samper-Ternent R; Silveira SL; Stevens A; Volpi E; Naik AD
    Ethn Dis; 2023 Apr; 33(2-3):76-83. PubMed ID: 38845738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.
    Oude Rengerink K; Kalkman S; Collier S; Ciaglia A; Worsley SD; Lightbourne A; Eckert L; Groenwold RHH; Grobbee DE; Irving EA;
    J Clin Epidemiol; 2017 Sep; 89():173-180. PubMed ID: 28502808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Series: Pragmatic trials and real world evidence: Paper 8. Data collection and management.
    Meinecke AK; Welsing P; Kafatos G; Burke D; Trelle S; Kubin M; Nachbaur G; Egger M; Zuidgeest M;
    J Clin Epidemiol; 2017 Nov; 91():13-22. PubMed ID: 28716504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Principles and procedures for data and safety monitoring in pragmatic clinical trials.
    Simon GE; Shortreed SM; Rossom RC; Penfold RB; Sperl-Hillen JAM; O'Connor P
    Trials; 2019 Dec; 20(1):690. PubMed ID: 31815644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing the design of pragmatic trials: key issues remain.
    Caro JJ; Ishak KJ
    J Comp Eff Res; 2012 Jul; 1(4):319-27. PubMed ID: 24237466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pragmatic clinical trials to advance research in children and adolescents with eating disorders.
    Norris ML; Spettigue W; Obeid N
    Int J Eat Disord; 2024 Jun; 57(6):1350-1356. PubMed ID: 38578194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement.
    Hohenschurz-Schmidt DJ; Cherkin D; Rice ASC; Dworkin RH; Turk DC; McDermott MP; Bair MJ; DeBar LL; Edwards RR; Farrar JT; Kerns RD; Markman JD; Rowbotham MC; Sherman KJ; Wasan AD; Cowan P; Desjardins P; Ferguson M; Freeman R; Gewandter JS; Gilron I; Grol-Prokopczyk H; Hertz SH; Iyengar S; Kamp C; Karp BI; Kleykamp BA; Loeser JD; Mackey S; Malamut R; McNicol E; Patel KV; Sandbrink F; Schmader K; Simon L; Steiner DJ; Veasley C; Vollert J
    Pain; 2023 Jul; 164(7):1457-1472. PubMed ID: 36943273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similarities and Differences Between Pragmatic Trials and Hybrid Effectiveness-Implementation Trials.
    Fortney JC; Curran GM; Lyon AR; Check DK; Flum DR
    J Gen Intern Med; 2024 Jul; 39(9):1735-1743. PubMed ID: 38627320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers.
    Sonnad SS; Mullins CD; Whicher D; Goldsack JC; Mohr PE; Tunis SR
    Contemp Clin Trials; 2013 Nov; 36(2):356-61. PubMed ID: 23999501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pragmatic Clinical Trials in Osteoporosis.
    Adami G; Saag KG; Danila MI
    Curr Osteoporos Rep; 2019 Dec; 17(6):521-526. PubMed ID: 31773402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical lessons learned for designing cluster randomized pragmatic clinical trials from the NIH Health Care Systems Collaboratory Biostatistics and Design Core.
    Cook AJ; Delong E; Murray DM; Vollmer WM; Heagerty PJ
    Clin Trials; 2016 Oct; 13(5):504-12. PubMed ID: 27179253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.